Whole Blood Multi‐ OMIC Analysis Is Effective in Clinical Interpretation of Splicing Aberrations in PLOD1 ‐Related Kyphoscoliotic Ehlers‐Danlos Syndrome
American Journal of Medical Genetics Part A · 2025
DOI: 10.1002/ajmg.a.64085 ↗Kurz gefasst
Fallbericht in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Federica Russo und 9 weiteren Autor:innen. Beteiligte Einrichtung: UOC Genetica Medica, Fondazione IRCCS-Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy. Hauptthemen laut MEDLINE: Ehlers-Danlos Syndrome, Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase, RNA Splicing, Scoliosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Ministero della Salute, Fondazione Telethon, Giovanni Armenise-Harvard Foundation.
Abstract (Originalsprache)
Kyphoscoliotic Ehlers‐Danlos syndrome (kEDS) Type 1 is a rare hereditary connective tissue disorder due to biallelic deleterious variants in PLOD1 and is mainly characterized by hypotonia, congenital kyphoscoliosis, eye fragility, hyperextensible skin, Marfanoid habitus, and joint hypermobility. In PLOD1 ‐kEDS, deleterious variants are typically loss‐of‐function alleles. Therefore, the identification of private non‐canonical splicing variants might deserve functional studies to refine their clinical interpretation. In a 7‐year‐old boy with congenital hypotonia, kyphoscoliosis, joint hypermobility, and arachnodactyly, exome sequencing revealed the homozygous variant c.1756‐13C > A in PLOD1 . This variant was previously annotated in public databases with conflicting pathogenicity criteria. In contrast to other EDS subtypes whose causative gene is not expressed in peripheral lymphocytes, whole blood RNA sequencing demonstrated a deleterious effect of the identified variant, which resulted in the incorporation of 11 intronic nucleotides and the generation of a premature stop codon. In this work, multi‐OMIC analysis on peripheral blood was a rapid and reliable tool to clinically characterize a non‐canonical splice site variant in PLOD1 ‐kEDS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UOC Genetica Medica, Fondazione IRCCS-Casa Sollievo Della Sofferenza, San Giovanni Rotondo, Italy.
- Pediatrics, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy.
- Laboratory of Medical Genetics, ASST Papa Giovanni XXIII, Bergamo, Italy.
- Telethon Institute of Genetics and Medicine (TIGEM), Armenise/Harvard Laboratory of Integrative Genomics, Pozzuoli, Italy.
- Department of Translational Medicine, University of Naples "Federico II", Naples, Italy.
- Genomics and Experimental Medicine Program, Scuola Superiore Meridionale (SSM, School of Advanced Studies), Naples, Italy.
ORCID-Profile: Marco Castori, Lucia Micale
Förderung
- Ministero della Salute
- Fondazione Telethon
- Giovanni Armenise-Harvard Foundation
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministry of Education, University and Research
Zitieren
APA
Russo, F., Daolio, C., Di Muro, E., Pezzoli, L., Goisis, L., Vaccaro, L., Iascone, M., Cacchiarelli, D., Castori, M., & Micale, L. (2025). Whole Blood Multi‐ OMIC Analysis Is Effective in Clinical Interpretation of Splicing Aberrations in PLOD1 ‐Related Kyphoscoliotic Ehlers‐Danlos Syndrome. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64085
Vancouver
Russo F, Daolio C, Di Muro E, Pezzoli L, Goisis L, Vaccaro L, et al. Whole Blood Multi‐ OMIC Analysis Is Effective in Clinical Interpretation of Splicing Aberrations in PLOD1 ‐Related Kyphoscoliotic Ehlers‐Danlos Syndrome. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64085
BibTeX
@article{Russo2025,
author = {Russo, Federica and Daolio, Cecilia and Di Muro, Ester and Pezzoli, Laura and Goisis, Lucrezia and Vaccaro, Lorenzo and Iascone, Maria and Cacchiarelli, Davide and Castori, Marco and Micale, Lucia},
title = {Whole Blood Multi‐ OMIC Analysis Is Effective in Clinical Interpretation of Splicing Aberrations in PLOD1 ‐Related Kyphoscoliotic Ehlers‐Danlos Syndrome},
journal = {American Journal of Medical Genetics Part A},
year = {2025},
doi = {10.1002/ajmg.a.64085}
}
EUVIMED